This study was conducted to assess the association of pulse pressure (PP) and visceral adiposity index (VAI) by gender in Korean adults.
Methods:
This study used the data of 4960 adults at age ≥20 years, from the 2015 Korean National Health and Nutrition Examination Survey.
Results:
In the overall population (n = 4960), after adjustment for related variables and with quartile 1 of VAI as a reference, the odds ratios of high PP (PP >60 mmHg) was significantly higher in quartile 3 [1.32 (95% confidence interval [CI], 1.02–1.71)] and quartile 4 of VAI [1.40 (95% CI, 1.07–1.83)]. In women (n = 2784), the OR of high PP, with quartile 1 of VAI as a reference, was significantly higher in quartile 3 [2.36 (95% CI, 1.55–3.61)] and quartile 4 of VAI [2.70 (95% CI, 1.77–4.12)]. In men (n = 2176), high PP was not associated with the quartiles of VAI. In addition, after adjustment for related variables, the PP level was positively associated with the quartiles of VAI in the overall population (P < 0.001) and women (P < 0.001), but not in men (P = 0.316).
Conclusions:
VAI was positively associated with PP in Korean women, but not in Korean men.
Get full access to this article
View all access options for this article.
References
1.
AmatoMC, GiordanoC, GaliaM, et al.Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 2010; 33:920–922.
2.
KouliGM, PanagiotakosDB, KyrouI, et al.adiposity index and 10-year cardiovascular disease incidence: The ATTICA study. Nutr Metab Cardiovasc Dis, 2017; 27:881–889.
3.
ChenYC, LaiSH, TsaiYW, et al.Visceral Adiposity Index as a predictor of chronic kidney disease in a relatively healthy population in Taiwan. J Ren Nutr, 2018; 28:91–100.
4.
YangF, WangG, WangZ, et al.Visceral adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness. PLoS One, 2014; 9:e104365.
5.
SnijderMB, FlyvbjergA, StehouwerCD, et al.Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: The Hoorn Study. Eur J Endocrinol, 2009; 160:387–395.
6.
KitagawaN, UshigomeE, MatsumotoS, et al.Threshold value of home pulse pressure predicting arterial stiffness in patients with type 2 diabetes: KAMOGAWA-HBP study. J Clin Hypertens (Greenwich), 2018; 20:472–477.
7.
Pääkkö TJW, Perkiömäki JS, Kesäniemi YA, et al.. Increasing ambulatory pulse pressure predicts the development of left ventricular hypertrophy during long-term follow-up. J Hum Hypertens, 2018; 32:180–189.
8.
LarstorpAC, AriansenI, GjesdalK, et al.Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: The Losartan Intervention For Endpoint (LIFE) reduction in hypertension study. Hypertension, 2012; 60:347–353.
9.
PanagiotakosDB, KromhoutD, MenottiA, et al.The relation between pulse pressure and cardiovascular mortality in 12,763 middle-aged men from various parts of the world: A 25-year follow-up of the seven countries study. Arch Intern Med, 2005; 165:2142–2147.
10.
ParkSY, OhHJ, YoonH. Association of Metabolic syndrome, Metabolic syndrome score and Pulse pressure in Korean Adults: Korea National Health and Nutrition Survey, 2012. J Korea Acad Industr Coop Soc, 2014; 15:5660–5667.
11.
LavieCJ, LadduD, ArenaR, et al.Healthy weight and obesity prevention: JACC Health Promotion Series. J Am Coll Cardiol, 2018; 72:1506–1531.
12.
JungUJ, ChoiMS. Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci, 2014; 15:6184–6223.
13.
BaysHE, González-CampoyJM, BrayGA, et al.Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther, 2008; 6:343–368.
14.
PadfieldGJ, DinJN, KoushiappiE, et al.Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: A first in human study. Heart, 2013; 99:1330–1335.
15.
HaunerH. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc, 2005; 64:163–199.
16.
OuchiN, ParkerJL, LugusJJ, et al.Adipokines in inflammation and metabolic disease. Nat Rev Immunol, 2011; 11:85–97.
17.
LeeJW, LeeHR, ShimJ, et al.Visceral abdominal fat as a determinant of arterial stiffness in overweight and obese women. J Korean Acad Fam Med, 2006; 27:815–821.
18.
Sutton-TyrrellK, NewmanA, SimonsickEM, et al.Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension, 2001; 38:429–433.
19.
SafarME. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens, 2001; 10:257–261.
20.
OhashiN, YamamotoH, HoriguchiJ, et al.Association between visceral adipose tissue area and coronary plaque morphology assessed by CT angiography. JACC Cardiovasc Imaging, 2010; 3:908–917.
21.
ZanoliL, OzturkK, CappelloM, et al.Inflammation and aortic pulse wave velocity: A multicenter longitudinal study in patients with inflammatory bowel disease. J Am Heart Assoc, 2019; 8:e010942.
22.
SabbatiniAR, FontanaV, LaurentS, et al.An update on the role of adipokines in arterial stiffness and hypertension. J Hypertens, 2015; 33:435–444.
23.
Gil-OrtegaM, Martín-RamosM, ArribasSM, et al.Arterial stiffness is associated with adipokine dysregulation in non-hypertensive obese mice. Vascul Pharmacol, 2016; 77:38–47.
24.
LanghammerB, BerglandA, RydwikE. the importance of physical activity exercise among older people. Biomed Res Int, 2018; 2018:7856823.
25.
GyllingAT, EriksenCS, GardeE, et al.The influence of prolonged strength training upon muscle and fat in healthy and chronically diseased older adults. Exp Gerontol, 2020; 136:110939.
26.
VassilatouE, LafoyianniS, VassiliadiDA, et al.Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome. Maturitas, 2018; 116:1–7.
27.
NusriantoR, TahaparyDL, SoewondoP. Visceral adiposity index as a predictor for type 2 diabetes mellitus in Asian population: A systematic review. Diabetes Metab Syndr, 2019; 13:1231–1235.
28.
XuC, MaZ, WangY, et al.Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up. Liver Int, 2018; 38:2294–2300.
29.
BuzzettiE, ParikhPM, GerussiA, et al.Gender differences in liver disease and the drug-dose gender gap. Pharmacol Res, 2017; 120:97–108.
30.
WilsgaardT, SchirmerH, ArnesenE. Impact of body weight on blood pressure with a focus sex differences: The Tromso study, 1986–1995. Arch Intern Med, 2000; 160:2847–2853.
31.
de SimoneG, DevereuxRB, RomanMJ, et al.Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension, 1994; 23:600–606.
32.
RiderOJ, LewandowskiA, NethonondaR, et al.Gender-specific differences in left ventricular remodelling in obesity: Insights from cardiovascular magnetic resonance imaging. Eur Heart J, 2013; 34:292–299.
33.
ArabiA, GarneroP, PorcherR, et al.Changes in body composition during post-menopausal hormone therapy: A 2 year prospective study. Hum Reprod, 2003; 18:1747–1752.
34.
BlaakE. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care, 2001; 4:499–502.
35.
GeerEB, ShenW. Gender differences in insulin resistance, body composition, and energy balance. Gend Med, 2009; 6Suppl 1:60–75.
36.
WangF, HanL, HuD. Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis. Clin Chim Acta, 2017; 464:57–63.
37.
LeeKS, GiMY, ChaJA, et al.The relationship between pulse pressure, insulin resistance, and beta cell function in non-diabetic Korean adults. Prim Care Diabetes, 2019; 13:422–429.
38.
Shahed-MorshedM, HaqT, FariduddinM, et al.The Association of Visceral Adiposity Index with Insulin Resistance in Adults with Prediabetes. Open J Endocr Metab Dis, 2021; 11:12–23.
39.
WilsgaardT, SchirmerH, ArnesenE. Impact of body weight on blood pressure with a focus on sex differences: The Tromso Study, 1986–1995. Arch Intern Med, 2000; 160:2847–2853.
40.
WenW, PengB, TangX, et al.Prevalence of high arterial stiffness and gender-specific differences in the relationships with classical cardiovascular risk factors. J Atheroscler Thromb, 2015; 22:706–717.
MozosI, MaidanaJP, StoianD, et al.Gender differences of arterial stiffness and arterial age in smokers. Int J Environ Res Public Health, 2017; 14:E565.
43.
MorrowEH. The evolution of sex differences in disease. Biol Sex Differ, 2015; 6:5.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
